Skip to content
TrialScanner

NCT03691974

Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee

Phase 2CompletedREGNLeadTEVACollaborator

Registry record

Lead sponsor
Regeneron Pharmaceuticals
Conditions
Osteoarthritis, Knee; Osteoarthritis, Hip
Primary completion
Jan 30, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03691974 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03691974: Study to Evaluate the... | TrialScanner